Rank;Global Rank;Institution;Country;Sector
1;33;Samsung Corp *;MUL;Companies
2;89;GlaxoSmithKline *;MUL;Companies
3;91;AstraZeneca *;MUL;Companies
4;122;Sanofi *;MUL;Companies
5;129;F Hoffmann-La Roche *;MUL;Companies
6;130;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies
7;144;GlaxoSmithKline, United Kingdom;GBR;Companies
8;150;Hoffmann-La Roche Ltd, United States;USA;Companies
9;154;Genentech Inc;USA;Companies
10;169;Boehringer Ingelheim *;MUL;Companies
11;172;Janssen;MUL;Companies
12;179;Boehringer Ingelheim GmbH Germany;DEU;Companies
13;199;Johnson & Johnson *;MUL;Companies
14;208;Bayer *;MUL;Companies
15;235;AstraZeneca, United States;USA;Companies
16;260;Boehringer Ingelheim, USA;USA;Companies
17;264;Merck *;MUL;Companies
17;264;Merck & Co Inc, United States;USA;Companies
19;270;Novartis *;MUL;Companies
20;288;GlaxoSmithKline, United States;USA;Companies
21;291;AstraZeneca, Sweden;SWE;Companies
22;346;AstraZeneca, United Kingdom;GBR;Companies
23;547;Novartis Pharmaceuticals, United States;USA;Companies
24;580;Novartis, Switzerland;CHE;Companies
25;625;Regeneron Pharmaceuticals Inc;USA;Companies
26;743;Medtronic *;MUL;Companies
27;747;Manipal Global Education Group *;MUL;Companies